Karim Abid

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


34 publications

2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | 2009 | 2007 | 2006 | 2005 | 2004 | 2002 | 2001 | 2000 |
2023
CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (<sup>123/131</sup>I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors.
Grand-Guillaume J., Mansi R., Gaonkar R.H., Zanger S., Fani M., Eugster P.J., Beck Popovic M., Grouzmann E., Abid K., 2023/09/07. Journal of translational medicine, 21 (1) p. 604. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9B802C61B336]
2022
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma.
Eugster P.J., Maurer J., Vocat C., Abid K., Matter M., Wuerzner G., Trepp R., Fischli S., Henzen C., Kolb W. et al., 2022/09/01. Clinica chimica acta; international journal of clinical chemistry, 534 pp. 146-155. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_569E60EE2BE0]
Quantification of serotonin and eight of its metabolites in plasma of healthy volunteers by mass spectrometry.
Eugster P.J., Dunand M., Grund B., Ivanyuk A., Fogarasi Szabo N., Bardinet C., Abid K., Buclin T., Grouzmann E., Chtioui H., 2022/08/10. Clinica chimica acta; international journal of clinical chemistry, 535 pp. 19-26. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7C0E1266F726]
Accurate Location of Catheter Tip With the Free-to-Total Metanephrine Ratio During Adrenal Vein Sampling.
Christou F., Pivin E., Denys A., Abid K.A., Zingg T., Matter M., Pechère-Bertschi A., Maillard M., Grouzmann E., Wuerzner G., 2022. Frontiers in endocrinology, 13 p. 842968. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CF212A67D096]
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
Mühlethaler-Mottet A., Uccella S., Marchiori D., La Rosa S., Daraspe J., Balmas Bourloud K., Beck Popovic M., Eugster P.J., Grouzmann E., Abid K., 2022. Frontiers in endocrinology, 13 p. 1027856. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7CBCA91E69DA]
2021
eIF4E3 forms an active eIF4F complex during stresses (eIF4FS) targeting mTOR and re-programs the translatome.
Weiss B., Allen G.E., Kloehn J., Abid K., Jaquier-Gubler P., Curran J.A., 2021/05/21. Nucleic acids research, 49 (9) pp. 5159-5176. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A5C2A23B434D]
The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation.
Abid K., Popovic M.B., Bourloud K.B., Schoumans J., Grand-Guillaume J., Grouzmann E., Mühlethaler-Mottet A., 2021/01/05. Oncotarget, 12 (1) pp. 49-60. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F6E0642966A2]
2020
Evaluation of a New <sup>177</sup>Lu-Labeled Somatostatin Analog for the Treatment of Tumors Expressing Somatostatin Receptor Subtypes 2 and 5.
Mansi R., Nicolas G.P., Del Pozzo L., Abid K.A., Grouzmann E., Fani M., 2020/09/11. Molecules, 25 (18) p. 4155. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A77CC199073C]
A new <sup>68</sup>Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting.
Mansi R., Abid K., Nicolas G.P., Del Pozzo L., Grouzmann E., Fani M., 2020/08/05. EJNMMI research, 10 (1) p. 90. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_30E2FD571A97]
2019
 
High concentration of plasma methoxytyramine: dopamine-producing tumour or Parkinson's disease therapy?
Chtioui H., Sadowski S.M., Winzeler B., Tschopp O., Grouzmann E., Abid K., 2019/07. Annals of clinical biochemistry, 56 (4) pp. 466-471. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50EB460BE1AC]
2018
Cellular effects of AP102, a somatostatin analog with balanced affinities for the hSSTR2 and hSSTR5 receptors.
Streuli J., Harris A.G., Cottiny C., Allagnat F., Daly A.F., Grouzmann E., Abid K., 2018/04. Neuropeptides, 68 pp. 84-89. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C117C7B22DCF]
2016
Pheochromocytoma Masked by Mutation in the TH Gene.
Abid K., Afshar K., Fontana E., Ducry J., Rotman S., Stauffer E., Fellmann F., Tschopp O., Bhuiyan Z.A., Grouzmann E., 2016/07. Clinical chemistry, 62 (7) pp. 924-928. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_475789A533F9]
 
Clinical and biochemical responses after Gamma Knife surgery for a dopamine-secreting paraganglioma: case report.
Tuleasca C., Jaquet Y., Schweizer V., Negretti L., Magaddino V., Maeder P., Abid K.A., Lhermitte B., Grouzmann E., Levivier M., 2016. Hormones (Athens, Greece), 15 (1) pp. 106-112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CD14D991325E]
2015
Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E., Tschopp O., Triponez F., Matter M., Bilz S., Brändle M., Drechser T., Sigrist S., Zulewski H., Henzen C. et al., 2015. Plos One, 10 (5) pp. e0125426. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_26B1C674A53D]
2014
Enzyme and acid deconjugation of plasma sulfated metanephrines.
Glauser M., Metrailler M., Gerber-Lemaire S., Centeno C., Seghezzi C., Dunand M., Abid K., Herren A., Grouzmann E., 2014. Clinica Chimica Acta; International Journal of Clinical Chemistry, 430 pp. 125-128. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B6C7D6A06DEF]
2013
 
High-throughput and sensitive quantitation of plasma catecholamines by ultraperformance liquid chromatography-tandem mass spectrometry using a solid phase microwell extraction plate.
Dunand M., Gubian D., Stauffer M., Abid K., Grouzmann E., 2013. Analytical Chemistry, 85 (7) pp. 3539-3544.
[DOI][WoS][Pmid][serval:BIB_DC2104614369]
 
Lack of Enantioselectivity in the SULT1A3-catalyzed Sulfoconjugation of Normetanephrine Enantiomers: An In Vitro and Computational Study.
Grouzmann E., Gualtierotti J.B., Gerber-Lemaire S., Abid K., Brakch N., Pedretti A., Testa B., Vistoli G., 2013. Chirality, 25 pp. 28-34. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA02AD236F60]
2012
 
Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma.
Grouzmann E., Matter M., Bilz S., Herren A., Triponez F., Henzen C., Kim K.S., Zulewski H., Buclin T., Brakch N. et al., 2012. Journal of Clinical Endocrinology and Metabolism, 97 (8) pp. 2773-2781.
[DOI][WoS][Pmid][serval:BIB_15AEE025DDEF]
Synthetic calibrators for the analysis of total metanephrines in urine: revisiting the conditions of hydrolysis.
Simonin J., Gerber-Lemaire S., Centeno C., Seghezzi C., Iglesias K., Abid K., Grouzmann E., 2012. Clinica Chimica Acta, 413 (11-12) pp. 998-1003. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F4DA47379F47]
2010
Cellular factors implicated in prion replication.
Abid K., Morales R., Soto C., 2010/06/03. FEBS letters, 584 (11) pp. 2409-2414. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7A30F6FE716E]
2009
Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein.
Abid K., Rochat B., Lassahn P.G., Stöcklin R., Michalet S., Brakch N., Aubert J.F., Vatansever B., Tella P., De Meester I. et al., 2009. Journal of Biological Chemistry, 284 (37) pp. 24715-24724.
[URN][DOI][WoS][Pmid][serval:BIB_9B09F50AB826]
2007
The prion strain phenomenon: molecular basis and unprecedented features.
Morales R., Abid K., Soto C., 2007/06. Biochimica et biophysica acta, 1772 (6) pp. 681-691. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A27B347E24C0]
In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease.
Liu R., Abid K., Pichardo J., Pazienza V., Ingravallo P., Kong R., Agrawal S., Bogen S., Saksena A., Cheng K.C. et al., 2007/01. The Journal of antimicrobial chemotherapy, 59 (1) pp. 51-58. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9CAE2093881C]
2006
The intriguing prion disorders
Abid K., Soto C., 2006/10. Cellular and Molecular Life Sciences, 63 (19-20) pp. 2342-2351.
[URN][DOI][WoS][Pmid][serval:BIB_7AB8D6FA8E01]
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.
Pietschmann T., Kaul A., Koutsoudakis G., Shavinskaya A., Kallis S., Steinmann E., Abid K., Negro F., Dreux M., Cosset F.L. et al., 2006/05/09. Proceedings of the National Academy of Sciences of the United States of America, 103 (19) pp. 7408-7413. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D90919F8880C]
Protein misfolding cyclic amplification for diagnosis and prion propagation studies.
Castilla J., Saá P., Morales R., Abid K., Maundrell K., Soto C., 2006. Methods in enzymology, 412 pp. 3-21. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4ECC21052C6B]
2005
An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.
Abid K., Pazienza V., de Gottardi A., Rubbia-Brandt L., Conne B., Pugnale P., Rossi C., Mangia A., Negro F., 2005/05. Journal of hepatology, 42 (5) pp. 744-751. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_60A0F70D097A]
2004
 
Immunohistochemical detection of hepatitis delta antigen.
Abid K., Negro F., 2004. Methods in molecular medicine, 95 pp. 107-111. Peer-reviewed.
[DOI][Pmid][serval:BIB_AF1F3FBA21A6]
2002
Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus.
Rubbia-Brandt L., Taylor S., Gindre P., Quadri R., Abid K., Spahr L., Negro F., 2002/08. The Journal of pathology, 197 (5) pp. 617-623. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0266FC684B4C]
The 4,977-base pair common deletion of mitochondrial DNA is not associated with steatosis in chronic hepatitis C patients.
Latorre P., Rubbia-Brandt L., Giostra E., Abid K., Negro F., 2002/01. Hepatology, 35 (1) pp. 239-240. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F3376DC39EDE]
2001
Detection of the negative-strand hepatitis C virus RNA in tissues: implications for pathogenesis.
Quadri R., Rubbia-Brandt L., Abid K., Negro F., 2001/11. Antiviral research, 52 (2) pp. 161-171. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AADBCB852611]
2000
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.
Rubbia-Brandt L., Quadri R., Abid K., Giostra E., Malé P.J., Mentha G., Spahr L., Zarski J.P., Borisch B., Hadengue A. et al., 2000/07. Journal of hepatology, 33 (1) pp. 106-115. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CA6AABC7CAE9]
A novel hepatitis C virus (HCV) subtype from Somalia and its classification into HCV clade 3.
Abid K., Quadri R., Veuthey A.L., Hadengue A., Negro F., 2000/06. The Journal of general virology, 81 (Pt 6) pp. 1485-1493. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_05E7BC554311]
Hepatitis C virus, the E2 envelope protein, and alpha-interferon resistance.
Abid K., Quadri R., Negro F., 2000/03/03. Science, 287 (5458) p. 1555. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3D029EC8CDF4]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University